euromedica clinical glutathione - sublinthion glutathione Clinical | 60

Jill James showing that children with autism have impaired antioxidant defense due to low glutathione levels

Injection sites can be near the area of injury or systemically, depending on the goal of treatment

Molecular Weight: 159.21 g/mol

Figure 5: Changes in tail motor function in response to treatment with BPC 157 Figure 6: Changes in tail spasticity in response to treatment with BPC 157 The results of the electrophysiology testing suggested that the rats subjected to EMG recordings after surgical spinal cord surgery and treatment with BPC 157, exhibited a significantly lower MUP in the muscles of the tail than was observed in the control group